Literature DB >> 1413848

Primary hyperparathyroidism in Austria: results of an 8-year prospective study.

B Niederle1, L Stamm, F Längle, E Schubert, W Woloszczuk, R Prager.   

Abstract

Serum calcium determinations in 45,217 hospitalized patients during an 8 year period revealed sustained hypercalcemia in 124 (0.3%) patients. Further clinical and biochemical investigations established primary hyperparathyroidism (PHP) in at least 40 (32%) patients, an incidence of PHP of 89.6 +/- 41.5 per 100,000 patients per year. The incidence of PHP in males and females was 31.5 and 124.2 per 100,000, respectively. The highest incidence was found in females greater than 66 years of age (268.8 per 100,000). Nineteen (48%) patients showed classical symptoms of PHP, 14 (35%) patients were minimally symptomatic, and 7 (17%) patients were asymptomatic. The incidence and symptomatology of PHP in Austria is nearly the same as in other countries. Because of the multiple actions of parathyroid hormone in the body, PHP can cause debilitating symptoms but too often it remains undiagnosed clinically. Routine calcium determinations are very important and PHP must always be considered in the differential diagnosis, especially in minimally symptomatic patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1413848     DOI: 10.1007/bf02067385

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  46 in total

1.  Familial hyperparathyroidism.

Authors:  T Christensson
Journal:  Ann Intern Med       Date:  1976-11       Impact factor: 25.391

Review 2.  Laboratory diagnosis of primary hyperparathyroidism.

Authors:  R Marcus
Journal:  Endocrinol Metab Clin North Am       Date:  1989-09       Impact factor: 4.741

3.  Comparison of discriminant analysis procedures in laboratory differentiation of hypercalcemia.

Authors:  D A Lacher; R R Baumann; J C Boyd
Journal:  Am J Clin Pathol       Date:  1988-06       Impact factor: 2.493

4.  Clinical findings in patients with hypercalcaemia. A final investigation based on biochemical screening.

Authors:  G Stenström; P A Heedman
Journal:  Acta Med Scand       Date:  1974-06

5.  Primary hyperparathyroidism: changing clinical, surgical and pathologic aspects.

Authors:  R C Haff; W C Black; W F Ballinger
Journal:  Ann Surg       Date:  1970-01       Impact factor: 12.969

6.  Primary hyperparathyroidism. Changing trends over fifty years.

Authors:  C Trigonis; B Hamberger; L O Farnebo; J Abarca; P O Granberg
Journal:  Acta Chir Scand       Date:  1983

7.  [Surgical treatment of adrenal diseases].

Authors:  M Rothmund; P K Wagner
Journal:  Chirurg       Date:  1983-02       Impact factor: 0.955

8.  Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests.

Authors:  F W Lafferty
Journal:  Arch Intern Med       Date:  1981-12

9.  [Hypercalcemia in hospitalized patients. Diagnostic and prognostic aspects].

Authors:  E Burkhardt; H J Kistler
Journal:  Schweiz Med Wochenschr       Date:  1981-12-19

10.  Incidence of hypercalcaemia and primary hyperparathyroidism in relation to the biochemical profile.

Authors:  J S Harrop; J E Bailey; J S Woodhead
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

View more
  1 in total

Review 1.  Parathyroid hormone-dependent hypercalcemia.

Authors:  Judit Toke; Attila Patócs; Katalin Balogh; Péter Gergics; Balázs Stenczer; Károly Rácz; Miklós Tóth
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.